LXEO – lexeo therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer [Yahoo! Finance]
Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer
Paula H. Cholmondeley Bought 96% More Shares In Lexeo Therapeutics [Yahoo! Finance]
How decentralisation can fill the gaps in Alzheimer's research [Yahoo! Finance]
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target raised by analysts at HC Wainwright from $21.00 to $23.00. They now have a "buy" rating on the stock.
Form EFFECT Lexeo Therapeutics, Inc.
Form 8-K Lexeo Therapeutics, Inc. For: Dec 18
Form S-3 Lexeo Therapeutics, Inc.
Form 4 Lexeo Therapeutics, Inc. For: Dec 10 Filed by: Townsend Richard Nolan
Form 144 Lexeo Therapeutics, Inc. Filed by: Townsend Richard Nolan
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.